Kodiak Sciences Inc (KOD)
2.81
+0.05
(+1.81%)
USD |
NASDAQ |
Jun 14, 16:00
2.805
0.00 (0.00%)
After-Hours: 20:00
Kodiak Sciences Accounts Payable (Quarterly): 2.485M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.485M |
December 31, 2023 | 13.61M |
September 30, 2023 | 38.59M |
June 30, 2023 | 12.35M |
March 31, 2023 | 6.262M |
December 31, 2022 | 9.13M |
September 30, 2022 | 15.61M |
June 30, 2022 | 20.63M |
March 31, 2022 | 13.07M |
December 31, 2021 | 12.43M |
September 30, 2021 | 13.76M |
June 30, 2021 | 2.738M |
March 31, 2021 | 9.176M |
Date | Value |
---|---|
December 31, 2020 | 8.646M |
September 30, 2020 | 5.269M |
June 30, 2020 | 7.034M |
March 31, 2020 | 4.506M |
December 31, 2019 | 2.619M |
September 30, 2019 | 1.67M |
June 30, 2019 | 2.529M |
March 31, 2019 | 1.754M |
December 31, 2018 | 1.05M |
September 30, 2018 | 1.724M |
June 30, 2018 | 2.472M |
December 31, 2017 | 3.356M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.67M
Minimum
Sep 2019
38.59M
Maximum
Sep 2023
10.11M
Average
8.888M
Median
Accounts Payable (Quarterly) Benchmarks
Avalo Therapeutics Inc | 0.916M |
Regeneron Pharmaceuticals Inc | 671.30M |
Ligand Pharmaceuticals Inc | 1.893M |
iBio Inc | 1.228M |
Dare Bioscience Inc | 4.040M |